Best Casino Stocks To Watch Right Now

ValuEngine upgraded shares of Century Casinos (NASDAQ:CNTY) from a hold rating to a buy rating in a report issued on Thursday.

Several other research firms have also recently issued reports on CNTY. Zacks Investment Research raised shares of Century Casinos from a sell rating to a hold rating in a research note on Tuesday, January 30th. TheStreet cut shares of Century Casinos from a b rating to a c+ rating in a research note on Friday, April 6th. Finally, BidaskClub cut shares of Century Casinos from a hold rating to a sell rating in a research report on Tuesday, February 6th. Two analysts have rated the stock with a sell rating, one has assigned a hold rating and three have given a buy rating to the company. The company currently has a consensus rating of Hold and a consensus target price of $11.00.

Best Casino Stocks To Watch Right Now: AXT Inc(AXTI)

Advisors’ Opinion:

  • [By Max Byerly]

    These are some of the news headlines that may have impacted Accern Sentiment’s scoring:

    Get AXT alerts:

    Gallium Arsenide Global Market Players by 2023- Sumitomo Electric, AXT and China Crystal Technologies (newspharmaceuticals.com) TheStreet Downgrades AXT (AXTI) to C+ (americanbankingnews.com) Is this stock is Overbought? AXT, Inc. (AXTI) (stockquote.review) What Investors Should Know? AXT, Inc. (AXTI) (mostvolatilestocks.com) Community rallies around valley high school, putting on its first musical in 20 years (yourcentralvalley.com)

    Several analysts have recently issued reports on AXTI shares. BidaskClub upgraded AXT from a “hold” rating to a “buy” rating in a research note on Wednesday, February 14th. Dougherty & Co reiterated a “buy” rating on shares of AXT in a research note on Thursday, February 22nd. B. Riley decreased their price target on AXT from $8.75 to $8.25 and set a “neutral” rating for the company in a research note on Thursday, February 22nd. Zacks Investment Research downgraded AXT from a “buy” rating to a “hold” rating in a research note on Monday, January 1st. Finally, BWS Financial restated a “buy” rating on shares of AXT in a research note on Tuesday, April 17th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $10.44.

  • [By Lisa Levin] Gainers
    Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares surged 115.8 percent to $4.3591. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity.
    Stellar Biotechnologies, Inc. (NASDAQ: SBOT) jumped 38.2 percent to $3.0251 after the company disclosed that it achieved robust viral clearance for its manufacturing process.
    Universal Corporation (NYSE: UVV) surged 26.7 percent to $61.40 after reporting fiscal Q4 results.
    Hudson Technologies Inc. (NASDAQ: HDSN) rose 18.9 percent to $2.58.
    Evolus, Inc. (NASDAQ: EOLS) shares gained 17.8 percent to $22.8009.
    The Cato Corporation (NYSE: CATO) shares gained 17.5 percent to $21.07 after the company posted better-than-expected first-quarter results.
    Tyme Technologies, Inc. (NASDAQ: TYME) rose 15.9 percent to $3.3613.
    Destination Maternity Corporation (NASDAQ: DEST) shares gained 15.5 percent to $3.35 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan.
    AXT, Inc. (NASDAQ: AXTI) rose 15 percent to $7.65.
    nLIGHT, Inc. (NASDAQ: LASR) gained 14.5 percent to $34.27 following Q1 results.
    Achieve Life Sciences, Inc. (NASDAQ: ACHV) rose 14.3 percent to $11.4303.
    Bilibili Inc.. (NASDAQ: BILI) shares climbed 13.9 percent to $14.16 after announcing Q1 results.
    Babcock & Wilcox Enterprises, Inc. (NYSE: BW) gained 13.2 percent to $2.91 after an amended 13D filing from Steel Partners Holdings shows a raised stake in the company from 6.99 million shares to 29.98 million shares, or a 17.8 percent stake.
    HUYA Inc. (NYSE: HUYA) gained 13.1
  • [By Logan Wallace]

    Texas Instruments (NASDAQ: TXN) and AXT (NASDAQ:AXTI) are both computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, valuation, dividends and risk.

  • [By Lisa Levin] Gainers
    Comstock Holding Companies, Inc. (NASDAQ: CHCI) shares climbed 154.95 percent to close at $5.15 on Thursday. Comstock reported conversion of the majority of its unsecured, short-term debt into non-convertible preferred equity.
    Tyme Technologies, Inc. (NASDAQ: TYME) jumped 33.45 percent to close at $3.87.
    Universal Corporation (NYSE: UVV) gained 29.72 percent to close at $62.85 after reporting fiscal Q4 results.
    Evolus, Inc. (NASDAQ: EOLS) shares rose 22.93 percent to close at $23.80.
    nLIGHT, Inc. (NASDAQ: LASR) jumped 21.52 percent to close at $36.37 following Q1 results.
    Hudson Technologies Inc. (NASDAQ: HDSN) gained 20.28 percent to close at $2.61.
    The Cato Corporation (NYSE: CATO) shares rose 19.57 percent to close at $21.45 after the company posted better-than-expected first-quarter results.
    AXT, Inc. (NASDAQ: AXTI) gained 18.8 percent to close at $7.90.
    Catasys, Inc. (NASDAQ: CATS) rose 16.33 percent to close at $6.41.
    HUYA Inc. (NYSE: HUYA) rose 15.68 percent to close at $23.09 on Thursday.
    Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) climbed 15.11 percent to close at $6.02 on Thursday after gaining 6.30 percent on Wednesday. Baird initiated coverage on Marinus Pharmaceuticals with an Outperform rating.
    Destination Maternity Corporation (NASDAQ: DEST) shares rose 14.48 percent to close at $3.32 after the board announced late Wednesday the election of four activist-backed director nominees. Three women and one man comprise the selected group championed by NGM Capital’s Nathan Miller and Kenosis Capital’s Peter O’Malley. Destination Maternity had advocated for another slate of three men and interim CEO Melissa Payner-Gregor. The new directors are Holly Alden, Marla Ryan, Anne-Charlotte Windal and Christopher Morgan.
    China Rapid Finance Limited (NYSE: XRF) gained 11.53 percent to close at $3.29 after announcing preliminary Q1 results.
    Bilibili Inc.. (NASDAQ: BILI) shares rose 11.33 pe

Best Casino Stocks To Watch Right Now: Apollo Investment Corporation(AINV)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Income investors are always on the lookout for investments that will produce ample income, and it’s hard to find companies that do better right now than business development companies. BDCs like Main Street Capital (NYSE:MAIN) and Apollo Investment (NASDAQ:AINV) make investments in different types of businesses, often providing capital through either debt or equity financing. Because BDCs often elect the favorable tax status of regulated investment companies, they have to distribute the vast majority of their taxable income to their shareholders, and that produces the impressive yields that both Main Street and Apollo give their investors.

  • [By Shane Hupp]

    BidaskClub upgraded shares of Apollo Investment (NASDAQ:AINV) from a hold rating to a buy rating in a research report released on Monday morning.

    A number of other equities research analysts also recently commented on the company. TheStreet upgraded Apollo Investment from a c rating to a b- rating in a research report on Friday, June 8th. Zacks Investment Research upgraded Apollo Investment from a hold rating to a buy rating and set a $6.00 price objective for the company in a research report on Thursday, April 12th. ValuEngine downgraded Apollo Investment from a buy rating to a hold rating in a research report on Wednesday, February 28th. Finally, National Securities reiterated a neutral rating and set a $6.00 price objective on shares of Apollo Investment in a research report on Monday, May 21st. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and six have assigned a buy rating to the company’s stock. The stock currently has an average rating of Hold and a consensus target price of $6.34.

  • [By Logan Wallace]

    Apollo Investment (NASDAQ:AINV) will be posting its quarterly earnings results before the market opens on Friday, May 18th. Analysts expect Apollo Investment to post earnings of $0.16 per share for the quarter.

  • [By Motley Fool Staff]

    Apollo Investment Corporation (NASDAQ:AINV)Q4 2018 Earnings Conference CallMay 18, 2018, 10:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Apollo Investment (NASDAQ:AINV)‘s stock had its “neutral” rating reiterated by investment analysts at National Securities in a research report issued to clients and investors on Monday. They presently have a $6.00 price target on the asset manager’s stock. National Securities’ target price indicates a potential upside of 6.19% from the stock’s current price.

Best Casino Stocks To Watch Right Now: Eaton Vance Floating Rate Income Trust(EFT)

Advisors’ Opinion:

  • [By Shane Hupp]

    Relative Value Partners Group LLC grew its holdings in Eaton Vance Floating-Rate Income Trust (NYSE:EFT) by 11.0% in the first quarter, HoldingsChannel reports. The firm owned 799,864 shares of the investment management company’s stock after purchasing an additional 79,578 shares during the period. Relative Value Partners Group LLC’s holdings in Eaton Vance Floating-Rate Income Trust were worth $11,958,000 as of its most recent SEC filing.

Best Casino Stocks To Watch Right Now: Synopsys, Inc.(SNPS)

Advisors’ Opinion:

  • [By Logan Wallace]

    These are some of the news headlines that may have effected Accern Sentiment’s analysis:

    Get Synopsys alerts:

    Synopsys, Inc. (SNPS) Receives Average Rating of “Buy” from Brokerages (americanbankingnews.com) Free Research Report as Applied Materials Revenues Grew 28.8%; Adjusted EPS Surged 54.4% (finance.yahoo.com) Synopsys IC Validator Certified by Samsung Foundry for 7nm Signoff Physical Verification (prnewswire.com) Synopsys Fusion Technology Enables Lower Power, Smaller Area, and Higher Performance on Samsung Foundry 7LPP Process with EUV (prnewswire.com) Synopsys Announces New Release of LucidShape Software for Automotive Lighting Design and Analysis (finance.yahoo.com)

    A number of equities analysts recently commented on SNPS shares. KeyCorp reaffirmed an “overweight” rating and set a $110.00 price target (up from $106.00) on shares of Synopsys in a research note on Thursday, February 22nd. Royal Bank of Canada reaffirmed a “buy” rating on shares of Synopsys in a research note on Friday, February 23rd. Zacks Investment Research cut shares of Synopsys from a “hold” rating to a “strong sell” rating in a research note on Monday, February 26th. BidaskClub cut shares of Synopsys from a “hold” rating to a “sell” rating in a research note on Tuesday, February 27th. Finally, ValuEngine raised shares of Synopsys from a “hold” rating to a “buy” rating in a research report on Thursday, April 12th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have assigned a buy rating to the company. Synopsys presently has an average rating of “Buy” and an average target price of $102.71.

  • [By Logan Wallace]

    Synopsys (NASDAQ:SNPS) had its price target raised by stock analysts at KeyCorp from $110.00 to $112.00 in a research report issued to clients and investors on Thursday. The firm currently has an “overweight” rating on the semiconductor company’s stock. KeyCorp’s price target would suggest a potential upside of 26.81% from the stock’s current price.

  • [By Motley Fool Staff]

    Synopsys (NASDAQ:SNPS) Q2 2018 Earnings Conference CallMay. 23, 2018 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Champlain Investment Partners LLC boosted its position in Synopsys, Inc. (NASDAQ:SNPS) by 3.9% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 686,287 shares of the semiconductor company’s stock after purchasing an additional 25,685 shares during the period. Champlain Investment Partners LLC owned about 0.46% of Synopsys worth $57,127,000 as of its most recent filing with the SEC.

Best Casino Stocks To Watch Right Now: Tandy Leather Factory, Inc.(TLF)

Advisors’ Opinion:

  • [By Shane Hupp]

    Tandy Leather Factory (NASDAQ: TLF) and Vera Bradley (NASDAQ:VRA) are both small-cap retail/wholesale companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings.

Best Casino Stocks To Watch Right Now: Achillion Pharmaceuticals Inc.(ACHN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Achillion Pharmaceuticals (NASDAQ:ACHN) – Research analysts at B. Riley reduced their FY2018 EPS estimates for shares of Achillion Pharmaceuticals in a research note issued to investors on Wednesday, May 2nd. B. Riley analyst M. Kumar now anticipates that the biopharmaceutical company will earn ($0.58) per share for the year, down from their previous estimate of ($0.55). B. Riley has a “Neutral” rating and a $3.50 price objective on the stock. B. Riley also issued estimates for Achillion Pharmaceuticals’ FY2019 earnings at ($0.64) EPS, FY2020 earnings at ($0.71) EPS, FY2021 earnings at ($0.70) EPS and FY2022 earnings at ($0.84) EPS.

  • [By Keith Speights]

    Skeptics might deride a comparison of Inovio Pharmaceuticals, Inc. (NASDAQ:INO) and Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) as an exercise in finding the biggest loser. Both companies continue to post huge net losses every quarter, and their stocks are down by at least 30% over the last 12 months.

  • [By Stephan Byrd]

    Achillion Pharmaceuticals (NASDAQ:ACHN) has been given an average recommendation of “Hold” by the nine brokerages that are currently covering the firm, MarketBeat reports. Two analysts have rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating on the company. The average 12 month price target among analysts that have covered the stock in the last year is $5.20.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Avenue Therapeutics, Inc. (NASDAQ: ATXI) rose 29.4 percent to $5.50 in pre-market trading after the company disclosed that its first pivotal Phase 3 trial of IV tramadol achieved the primary and key secondary endpoints.
    MB Financial, Inc. (NASDAQ: MBFI) rose 16.8 percent to $51.00 in pre-market trading. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock.
    LiveXLive Media, Inc. (NASDAQ: LIVX) rose 9.3 percent to $5.40 in pre-market trading after falling 28.92 percent on Friday.
    Celyad SA (NASDAQ: CYAD) shares rose 9 percent to $29.30 in pre-market trading after climbing 3.26 percent on Friday.
    Ethan Allen Interiors Inc. (NYSE: ETH) rose 6.7 percent to $26.40 in pre-market trading after gaining 1.64 percent on Friday.
    Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) rose 5.4 percent to $3.90 in pre-market trading after gaining 3.06 percent on Friday.
    Acacia Communications, Inc. (NASDAQ: ACIA) rose 5.2 percent to $34.70 in pre-market trading after gaining 1.38 percent on Friday.
    Westinghouse Air Brake Technologies Corporation (NYSE: WAB) rose 5.1 percent to $100 in pre-market trading. General Electric Company (NYSE: GE) agreed to merge its transportation unit with Wabtec.
    Sunrun Inc. (NASDAQ: RUN) shares rose 4.7 percent to $11.50 in pre-market trading.
    Nasdaq, Inc. (NASDAQ: NDAQ) shares rose 4.3 percent to $93.98 in the pre-market trading session.
    LaSalle Hotel Properties (NYSE: LHO) shares rose 4.2 percent to $33.25 in pre-market trading. Blackstone Group LP (NYSE: BX) will buy LaSalle Hotel Properties in a $4.8 billion deal, Bloomberg reported.
    Monro, Inc. (NASDAQ: MNRO) shares rose 4 percent to $58.35 in pre-market trading as the company posted upbeat quarterly earnings and disclosed that it has acquired Free Service Tire.
    HUYA Inc. (NYSE: HUYA) rose 3.7 percent to $19.75 in pre-market trading after falling 4.80 percent on Friday.

    Find out what's going

Leave a Reply

Your email address will not be published. Required fields are marked *